
Sign up to save your podcasts
Or


Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.
By Chemistry World4.7
182182 ratings
Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.

524 Listeners

1,719 Listeners

534 Listeners

297 Listeners

392 Listeners

45 Listeners

988 Listeners

15 Listeners